Navigation Links
Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
Date:8/25/2009

fectively manage clinical trials through an integrated multi-component, comprehensive solution. The Company delivers a complete portfolio of software products that were created in order to accelerate clinical research data from investigative sites to clinical trial sponsors and ultimately the FDA, faster and more efficiently than manual methods or loosely integrated technologies. DATATRAK's eClinical((TM)) software suite can be deployed worldwide through an ASP offering or in a licensed Enterprise Transfer model that fully empowers its clients. The DATATRAK software suite and its earlier versions have successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 59 countries. DATATRAK International, Inc.'s product suite has been utilized in some aspect of the clinical development of 16 drugs and one medical device that have received regulatory approval from either the United States Food and Drug Administration or counterpart European bodies. DATATRAK International, Inc. has offices located in Cleveland, Ohio, and Bryan, Texas. Visit the DATATRAK International, Inc. web site at www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors (including those specified below) which are difficult to predict and, in many instances, are beyond the control of the Company. Factors that may cause actual results to differ materially from those in the forward-looking statements include the limited operating history on which the Company's performance can be evaluated; the ability of the Company to continue to enhance its software product
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
2. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
3. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
4. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
5. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
6. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
7. XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma
8. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
9. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
10. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
11. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  Diomics today announced that ... senior official, has joined the company,s board of directors, ... Intelligence Studies Project and Clinical Professor at the Lyndon ... of Texas at Austin. "Steve brings ... served 28 years as a member of CIA,s clandestine ...
(Date:6/3/2015)... CORONA, Calif. , June 3, 2015  Giving ... is the ultimate mission of the International Academy ... offer treatments and resources that are at the forefront ... eye care professionals in the technology and latest treatment ... that has not been remedied with traditional means. Recently, ...
(Date:6/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/t3kkhg/the_future_of ) has ... of Pharmaceutical Outsourcing" report to their offering. ... need to develop better drugs with high success ... increasingly utilizing external resources to increase their efficiency ... internal operation. Their outsourcing demands and proportions have ...
Breaking Medicine Technology:Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 3International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 4The Future of Pharmaceutical Outsourcing: 2015 Report 2
... (NYSE: AME ) today announced that it ... of custom, fine-featured components used in the medical device ... in Montevideo, MN, has annual sales of approximately $25 ... of businesses that serve the highly attractive medical device ...
... NEW YORK, April 28, 2011 Reportlinker.com ... is available in its catalogue: ... Healthcare System and Drug Regulatory Overview: Cost-containment ... http://www.reportlinker.com/p0487111/Pharmaceutical-Key-Trends-2011---Healthcare-System-and-Drug-Regulatory-Overview-Cost-containment-and-regulatory-pressures-intensify.html ...
Cached Medicine Technology:AMETEK ACQUIRES AVICENNA TECHNOLOGY 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 5Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 6
(Date:6/3/2015)... BC (PRWEB) June 03, 2015 Vancouver ... announced that the firm will now handle personal injury ... Greater Vancouver on the rise, more and more people ... year bus accidents cause needless suffering, serious injury and ... a result of a bus accident in BC you ...
(Date:6/3/2015)... June 03, 2015 Array Health ... technology, has announced that CEO Jonathan Rickert will present ... on June 4, 2015. The session will address ... are disrupting traditional business models in health care, and ... , WHAT: Digital Transformation and the Health Care ...
(Date:6/3/2015)... 2015 A group of nine authors ... a Global Inspire Award at DIA’s upcoming Annual Meeting. ... volunteers for their leadership, level of excellence, and commitment ... The recipients of the Author(s) of the Year Award, ... article has made a significant impact in advancing medical ...
(Date:6/3/2015)... 2015 Z-Medica®, LLC, a leading developer ... has been designated as National Safety Month by the ... Police Department for its commitment to public safety. ... Individual First Aid Kits (IFAK) over 100 times in ... stabbings or traffic accidents. Each kit is equipped with ...
(Date:6/3/2015)... NC (PRWEB) June 03, 2015 Researchers ... two biomarkers for mesothelioma and say the tried-and-true marker ... just posted an article on the research. Click ... the University’s National Center for Asbestos Related Diseases say, ... positive results, it is still preferable to fibulin-3 for ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2
... Secretary of State Colin Powell, a strong advocate for national ... the world and call upon them to continue their efforts ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081014/DC38855LOGO ) ... the importance and value of volunteerism as part of the ...
... FDA compliant solution that works within minutes to relieve the ... on stings caused by the Portuguese man-of-war. Jellyfish Squish(TM) ... can be purchased online and at select stores including drug ... of 2009 Dr. Peter Verity, a world renowned marine biologist ...
... August and September, PF Week Sept. 14 - 21 ... for Pulmonary Fibrosis (CPF) announced today it has scheduled its 2009 ... The primary goals of this year,s activity are to ensure passage ... of Congress and in communities nationwide. , , Specifically, the ...
... ... ... National HIV Testing Day, June 27, by encouraging people of all ages to learn about HIV, ... vaginal fluids or breast milk. Exposure to any of these fluids can put you at ...
... and Medicare plan participants in Ga. now have access ... , June 25 UnitedHealthcare and ... services of Fusion Sleep,s sleep disorder program available to ... , , "Fusion Sleep provides a very important ...
... French . , Montreal, June 25th 2009 ... have two choices: inject them with medication to dissolve the ... open the blocked artery (primary percutaneous coronary intervention (PCI)). Guidelines ... that do not take "real-life" conditions into account. The latest ...
Cached Medicine News:Health News:Colin Powell Applauds Lions for Leadership in Volunteerism as Interest in Volunteer Service Grows 2Health News:Popular Jellyfish Sting Treatment Also Proven Effective on Stings From Portuguese Man-of-War 2Health News:Popular Jellyfish Sting Treatment Also Proven Effective on Stings From Portuguese Man-of-War 3Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 2Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 3Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 4Health News:Planned Parenthood Recognizes National HIV Testing Day 2Health News:UnitedHealthcare and Fusion Sleep Announce New Agreement 2Health News:Research: Improving treatment of patients with heart attack 2
...
... A wide range of miniTHERM incubators is ... appropriate application solution for their specific requirements. ... liters, are compact and extremely space saving. ... microwave oven. It is possible to stack ...
... miniTHERM incubators is available, ensuring the customers ... their specific requirements. miniTHERM incubators have a ... extremely space saving. Their size corresponds approximately ... possible to stack up to three units ...
... miniTHERM incubators is available, ensuring the customers ... their specific requirements. miniTHERM incubators have a ... extremely space saving. Their size corresponds approximately ... possible to stack up to three units ...
Medicine Products: